{"id":"W2111658171","doi":"10.1016/j.ygyno.2015.04.009","title":"A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: A trial of the Princess Margaret, Chicago and California Phase II Consortia","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre; Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Ovarian cancer; Fallopian tube; Internal medicine; Gastroenterology; Clinical endpoint; Fallopian tube cancer; Phases of clinical research; Progression-free survival; Chemotherapy; Gynecology; Urology; Surgery; Cancer; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006356622,0.0002643116,0.001160805,0.000125657,0.00009710189,0.000007273183,0.0002014106,0.0002265413,0.0004777585],"category_scores_gemma":[0.0006299574,0.0001424079,0.0001346045,0.0003641455,0.0003109331,0.00003546812,0.000218909,0.0002950488,0.000001314871],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008220605,"about_ca_system_score_gemma":0.002132313,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009801167,"about_ca_topic_score_gemma":0.01183107,"domain_scores_codex":[0.9974967,0.0004398658,0.0008696756,0.0005039774,0.0003245113,0.0003653332],"domain_scores_gemma":[0.9983622,0.0003730636,0.0004519636,0.0003970215,0.0001782737,0.0002374084],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.423502,0.2236189,0.1500114,0.0003933917,0.00188648,0.001518136,0.01888814,0.0000583204,0.0001965317,0.0002125449,0.002364462,0.1773496],"study_design_scores_gemma":[0.6397647,0.2906587,0.0267067,0.0001670166,0.001511714,0.0001329241,0.007651937,0.0003838279,0.0001811824,0.00003280614,0.03253994,0.000268592],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896408,0.0004965303,0.000001199982,0.003912365,0.001024949,0.004181247,0.0001742533,0.00001848041,0.0005501512],"genre_scores_gemma":[0.9979706,0.0003442023,0.0001608193,0.00027565,0.0001361165,0.000932312,0.00001318907,0.00001572347,0.0001513393],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2162627,"threshold_uncertainty_score":0.6602013,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09231435434348424,"score_gpt":0.3957769751900425,"score_spread":0.3034626208465582,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}